Tian'an Pharmaceutical Co., Ltd.
Other OTCTotal Valuation
Tian'an Pharmaceutical Co., Ltd. carries a market capitalization of 125,962.00, placing it among publicly traded companies globally.
| Market Cap | 125,962.00 |
| Enterprise Value | N/A |
Share Statistics
Tian'an Pharmaceutical Co., Ltd. currently has 13.94M shares outstanding.
| Shares Outstanding | 13.94M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
Tian'an Pharmaceutical Co., Ltd. trades at a trailing price-to-earnings ratio of 17.81. The price-to-sales ratio is 5.26, and the price-to-book ratio stands at 11.25.
| PE Ratio | 17.81 |
| PS Ratio | 5.26 |
| PB Ratio | 11.25 |
| P/TBV Ratio | 4.19 |
| P/FCF Ratio | 21.80 |
| P/OCF Ratio | 21.85 |
Financial Position
Tian'an Pharmaceutical Co., Ltd. maintains a current ratio of 14.23, meaning it holds 14.2x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 14.23 |
| Quick Ratio | 13.28 |
| Debt / Equity | N/A |
| Debt / EBITDA | N/A |
| Interest Coverage | N/A |
Financial Efficiency
| Return on Equity (ROE) | 86.32 |
| Return on Assets (ROA) | 23.75 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 4.95 |
Taxes
Over the trailing twelve months, Tian'an Pharmaceutical Co., Ltd. has paid 556,096.00 in income taxes, reflecting an effective tax rate of 15.03.
| Income Tax | 556,096.00 |
| Effective Tax Rate | 15.03 |
Stock Price Statistics
Tian'an Pharmaceutical Co., Ltd.'s stock has gained approximately 275% over the past 52 weeks. The 50-day moving average sits at 0.01, while the 200-day moving average is 0.01.
| Beta (5Y) | N/A |
| 52-Week Price Change | 275% |
| 50-Day Moving Average | 0.01 |
| 200-Day Moving Average | 0.01 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Tian'an Pharmaceutical Co., Ltd. generated 10.65M in revenue and converted that into 3.14M in net income, yielding earnings per share of 0.22. EBITDA reached 4.31M, while operating income came in at 3.81M.
| Revenue | 10.65M |
| Gross Profit | 7.30M |
| Operating Income | 3.81M |
| Pretax Income | 3.70M |
| Net Income | 3.14M |
| EBITDA | 4.31M |
| EBIT | 3.81M |
| Earnings Per Share (EPS) | 0.22 |
Balance Sheet
Total book value stands at 4.98M, with working capital of 11.28M providing operational flexibility.
| Cash & Cash Equivalents | 8.23M |
| Total Debt | N/A |
| Net Debt | -8.23M |
| Equity (Book Value) | 4.98M |
| Book Value Per Share | 0.36 |
| Working Capital | 11.28M |
Cash Flow
Tian'an Pharmaceutical Co., Ltd. produced 2.56M in operating cash flow over the past twelve months. After subtracting -6,642.00 in capital expenditures, free cash flow totaled 2.56M - equivalent to 0.18 per share.
| Operating Cash Flow | 2.56M |
| Capital Expenditures | -6,642.00 |
| Free Cash Flow | 2.56M |
| FCF Per Share | 0.18 |
Margins
Tian'an Pharmaceutical Co., Ltd. operates with a gross margin of 68.54, reflecting its pricing power and cost economics. The operating margin of 35.81 and net profit margin of 29.51 provide insight into operational efficiency.
| Gross Margin | 68.54 |
| Operating Margin | 35.81 |
| Pretax Margin | 34.73 |
| Profit Margin | 29.51 |
| EBITDA Margin | 40.48 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | N/A |
| FCF Yield | 4.59 |
Scores
Tian'an Pharmaceutical Co., Ltd. posts an Altman Z-Score of 42.45, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 42.45 |